An internal standard for the quantification of arachidonoyl glycine
Related Products
Unlabeled Version(s)
90051Arachidonoyl Glycine
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Arachidonoyl Glycine-d8

Item No. 10007531

Technical Information
Formal Name
N-[(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraen-1-yl-5,6,8,9,11,12,14,15-d8]-glycine
CAS Number
1159908-44-7
Synonyms
  • NAGly-d8
  • N-Arachidonyl Glycine-d8
Molecular Formula
C22H27D8NO3
Formula Weight
Purity
≥99% deuterated forms (d1-d8)
A 1 mg/ml solution in ethanol
DMF: 20 mg/mlDMSO: 15 mg/mlEthanol: 25 mg/mlPBS (pH 7.2): 2 mg/ml
SMILES
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCC(=O)O
InChi Code
InChI=1S/C22H35NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21(24)23-20-22(25)26/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-20H2,1H3,(H,23,24)(H,25,26)/b7-6-,10-9-,13-12-,16-15-/i6D,7D,9D,10D,12D,13D,15D,16D
InChi Key
YLEARPUNMCCKMP-FBFLGLDDSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Arachidonoyl glycine-d8 (NAGly-d8) is intended for use as an internal standard for the quantification of NAGly by GC- or LC-MS. NAGly has been isolated from cell cultures treated with arachidonoyl ethanolamide (AEA), from extracts of mammalian brain, and has also been synthesized as an analog of AEA for structure/activity testing.1,2,3,4 NAGly may be produced endogenously via oxidation of AEA, or by transacylation of arachidonoyl coenzyme A. NAGly is reported to have analgesic activities in whole animal experiments.1,2,3 Since it seems to be a very poor ligand for the CB1 receptor, these effects are probably mediated via other signalling pathways.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Burstein, S.H., Rossetti, R.G., Yagen, B., et alOxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat. 61(1-2), 29-41 (2000).

    2. Huang, S.M., Bisogno, T., Petros, T.J., et alIdentification and characterization of an endogenous anandamide-like compound: N-Arachidonylglycine (NAGly). ICRS 2001 Symposium on the Cannabinoids 78 (2001).

    3. Huang, S.M., Bisogno, T., Petros, T.J., et alIdentification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. The Journal of Biological Chemisty 276(46), 42639-42644 (2001).

    4. Sheskin, T., Hanus, L., Slager, J., et alStructural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J. Med. Chem. 40(5), 659-667 (1997).